Latest Coronavirus news
Pfizer COVID-19 Pill to Be Made, Sold Cheaply in 95 Poor Countries
posted November 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Pfizer Asks FDA for Emergency Approval of Its COVID-19 Antiviral Pill
posted November 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Prior SARS-CoV-2 Infection Ups Protection for Vaccinated
posted November 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
ACR: Lupus Patients Can Have Low Immune Response to COVID-19 Vaccines
posted November 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus 
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia 
Anifrolumab Tied to Lower Hospitalization, Infection Risk in Lupus 
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Parts of the World Seeing New COVID-19 Variant 
HHS, NIH Unveil Vaccine Initiative to Protect Against Future Pandemics 
Hospital-Onset SARS-CoV-2 Infection During Omicron Linked to Morbidity Monthly Specialist Briefings
Stay Connected
